Spain· ES:03268004
CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
A colesevelam product containing colesevelam, registered in Spain by Cheplapharm Arzneimittel Gmbh. The same ATC class is registered in 14 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Colesevelam is registered in 14 of 19 countries.
Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 8 of them publish a price we can compare per daily dose
Colesevelam · ATC C10AC04
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of colesevelam costs, country by country.
Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.
- Spain: $5.96 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Colesevelam · price per daily dose (3.75 g)
USD · FX 28 Sept 2026
- ES Spain$5.96
- US United States$1.57 (acquisition cost)
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- colesevelam
- Manufacturer
- Cheplapharm Arzneimittel Gmbh
- Country
- Spain (ES)
- ATC code
- C10AC04
- ATC class
- Colesevelam
- Defined daily dose
- 3.75 g, O
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo660113180EUR 156.95
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for colesevelam.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Colesevelam · interactions on record
63 records
- 5 severe
- 58 moderate
Most severe, free to view
- BexaroteneL01XF03severe
- BexarotenL01XX25severe
- Mycophenolic acidL04AA06severe
- TeriflunomidL04AA31severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Colesevelam in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed74f0ab-2007-4266-a964-1f0d33a190a1 GET /v1/drugs/ed74f0ab-2007-4266-a964-1f0d33a190a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1206399600000}",
"nregistro": "03268004",
"substance": "colesevelam"
}See everything about colesevelam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.